Grant winners

July 28, 2011


Fellowship Awards

• Award winner: Karen Leeder

• Institution: University of Oxford

• Value: £88,657

Spectres of the GDR: The haunting of the Berlin Republic

• Award winner: Suzanne Romaine

• Institution: University of Oxford

• Value: £55,1

Linguistic diversity, biodiversity and poverty: Global patterns and priorities

• Award winner: Abdulrazzak Patel

• Institution: University of Oxford

• Value: £60,126

The Arab Renaissance: the making of the intellectual and humanist movement

• Award winner: Neal Curtis

• Institution: University of Nottingham

• Value: £43,833

On sovereignty and superheroes

• Award winner: Marcos Martinón-Torres

• Institution: University College London

• Value: £74,975

The archaeology of alchemy and chemistry in the early modern world


Sir Henry Wellcome Postdoctoral Fellowships

These awards are worth £250,000 over four years.

• Award winner: Stephen Fleming

• Institution: University of Oxford

Computational and biological foundations of metacognition

• Award winner: Kevin Maringer

• Institution: University of Bristol

Unravelling the interplay between dengue virus and the host unfolded protein response and interferon pathways

• Award winner: Laura Pearce

• Institution: University of Cambridge

Investigation of the molecular basis by which mutations in SH2B1 lead to human obesity and insulin resistance


Efficacy and Mechanism Evaluation (EME) programme

• Award winner: Paul Little

• Institution: University of Southampton

• Value: £237,537

Alexander technique and supervised physiotherapy exercises in back pain (ASPEN) feasibility study


3Rs Research Funding Scheme

• Award winner: Roland Ashford

• Institution: Veterinary Laboratories Agency

• Value: £38,240

Pilot study: the use of gene expression profiles to predict protective immunity without the need for disease challenge


Health Technology Assessment (HTA) programme

• Award winner: Khalid Khan

• Institution: University of London

• Value: £1,779,269

Anti-epileptic drug (AED) management in pregnancy: An evaluation of effectiveness, cost-effectiveness and acceptability of dose adjustment strategies

Pregnancy can be stressful and dangerous, but the risks are even greater for women with epilepsy. Seizures during pregnancy are thought to negatively influence children, but so too is a mother's use of anti-epileptic drugs. There is conflict over the best way to treat the condition during pregnancy: administering the drugs in response to falling blood levels (preventive) or responding to clinical features such as worsening seizures (reactive). The study will compare the clinical effectiveness, cost-effectiveness, safety and acceptability of the two strategies. By gauging how seizure severity varies between the methods, researchers hope to help women and their doctors decide which treatment is best for them.

You've reached your article limit.

Register to continue

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments

Have your say

Log in or register to post comments

Featured Jobs

Most Commented

Monster behind man at desk

Despite all that’s been done to improve doctoral study, horror stories keep coming. Here three students relate PhD nightmares while two academics advise on how to ensure a successful supervision

Sir Christopher Snowden, former Universities UK president, attacks ratings in wake of Southampton’s bronze award

celebrate, cheer, tef results

Emilie Murphy calls on those who challenged the teaching excellence framework methodology in the past to stop sharing their university ratings with pride

Reflection of man in cracked mirror

To defend the values of reason from political attack we need to be more discriminating about the claims made in its name, says John Hendry

But the highest value UK spin-off companies mainly come from research-intensive universities, latest figures show